Xylans are heteropolysaccharides widely distributed in plant cell walls, functioning as essential hemicelluloses that interact with cellulose and lignin to support structural integrity and vascular development.

Chemical Structure

Xylans consist of a linear backbone of β-(1→4)-linked D-xylopyranosyl residues. Structural variants include glucuronoxylan (GX), characterized by α-1,2-linked glucuronic acid (GlcA) or 4-O-methylglucuronic acid (MeGlcA) substituents, and extensive O-acetylation in secondary cell walls. In solution, xylans adopt a threefold helical screw conformation, transitioning to a twofold conformation within cell walls to strengthen molecular interactions. Arabinoxylans incorporate arabinose side chains, contributing to extensive structural diversity across plant species and tissues.

Sources and Biosynthesis

Xylans are abundant in lignocellulosic biomass, agricultural by-products, and plant secondary cell walls. Their biosynthesis occurs in the Golgi lumen and involves key glycosyltransferases that elongate chains from UDP-xylose. Charophyte algae represent the earliest evolutionary origin of xylan synthesis in land plant ancestors. Mutants deficient in xylan display impaired vascular differentiation. Extraction from plant species such as Dinizia excelsa yields xylan variants with unique substitution patterns.

Health Benefits

Xylans function as non-digestible dietary fibers with notable prebiotic properties, promoting the proliferation of beneficial gut microorganisms such as Lactobacillus and Bifidobacterium. They help modulate the intestinal microbiome and reduce inflammation. In addition, xylans exhibit antioxidant, antimicrobial, anticoagulant, antitumor, and immunomodulatory activities, including stimulation of anti-inflammatory cytokines while maintaining low toxicity. Xylooligosaccharides (XOS), generated from xylan hydrolysis, contribute to metabolic regulation in conditions such as obesity, diabetes, and dyslipidemia.

Applications and Limitations

Xylans have diverse industrial and biomedical applications, serving as biodegradable feedstocks for biofuels, hydrogels, drug delivery systems, and functional foods due to their non-toxic nature and capacity for molecular self-association. Enzymatic hydrolysis produces XOS suitable for nutraceutical applications. However, the structural complexity of xylans presents challenges for bioprocessing optimization. Further research is needed to define optimal dosing and to conduct long-term clinical studies extending beyond microbiome-focused outcomes.